1 Scope of the Report 1.1 Market Introduction 1.2 Years Considered 1.3 Research Objectives 1.4 Market Research Methodology 1.5 Research Process and Data Source 1.6 Economic Indicators 1.7 Currency Considered 2 Executive Summary 2.1 World Market Overview 2.1.1 Global Anti-tumor Drug Market Size 2016-2026 2.1.2 Anti-tumor Drug Market Size CAGR by Region 2020 VS 2021 VS 2026 2.2 Anti-tumor Drug Segment by Type 2.2.1 Cytotoxic Drugs 2.2.2 Cytotoxic Drugs 2.3 Anti-tumor Drug Market Size by Type 2.3.1 Global Anti-tumor Drug Market Size CAGR by Type 2.3.2 Global Anti-tumor Drug Market Size Market Share by Type (2016-2021) 2.4 Anti-tumor Drug Segment by Application 2.4.1 Alkylating Agents 2.4.2 Anti-Metabolism Drugs 2.4.3 Platinum Antineoplastic Agents 2.4.4 Anthracycline Antitumor Drugs 2.4.5 Microtubule Stabilizer 2.4.6 Endocrine Therapy Drugs 2.4.7 Immunotherapy Drugs 2.4.8 Gene Therapy Drugs 2.4.9 Targeted Antineoplastic Drugs 2.5 Anti-tumor Drug Market Size by Application 2.5.1 Global Anti-tumor Drug Market Size CAGR by Application 2.5.2 Global Anti-tumor Drug Market Size Market Share by Application (2016-2021) 3 Anti-tumor Drug Market Size by Players 3.1 Anti-tumor Drug Market Size Market Share by Players 3.1.1 Global Anti-tumor Drug Revenue by Players (2019-2021E) 3.1.2 Global Anti-tumor Drug Revenue Market Share by Players (2019-2021E) 3.2 Global Anti-tumor Drug Key Players Head office and Products Offered 3.3 Market Concentration Rate Analysis 3.3.1 Competition Landscape Analysis 3.3.2 Concentration Ratio (CR3, CR5 and CR10) (2019-2021E) 3.4 New Products and Potential Entrants 3.5 Mergers & Acquisitions, Expansion 4 Anti-tumor Drug by Regions 4.1 Anti-tumor Drug Market Size by Regions (2016-2021) 4.2 Americas Anti-tumor Drug Market Size Growth (2016-2021) 4.3 APAC Anti-tumor Drug Market Size Growth (2016-2021) 4.4 Europe Anti-tumor Drug Market Size Growth (2016-2021) 4.5 Middle East & Africa Anti-tumor Drug Market Size Growth (2016-2021) 5 Americas 5.1 Americas Anti-tumor Drug Market Size by Country (2016-2021) 5.2 Americas Anti-tumor Drug Market Size by Type (2016-2021) 5.3 Americas Anti-tumor Drug Market Size by Application (2016-2021) 5.4 United States 5.5 Canada 5.6 Mexico 5.7 Brazil 6 APAC 6.1 APAC Anti-tumor Drug Market Size by Region (2016-2021) 6.2 APAC Anti-tumor Drug Market Size by Type (2016-2021) 6.3 APAC Anti-tumor Drug Market Size by Application (2016-2021) 6.4 China 6.5 Japan 6.6 Korea 6.7 Southeast Asia 6.8 India 6.9 Australia 7 Europe 7.1 Europe Anti-tumor Drug by Country (2016-2021) 7.2 Europe Anti-tumor Drug Market Size by Type (2016-2021) 7.3 Europe Anti-tumor Drug Market Size by Application (2016-2021) 7.4 Germany 7.5 France 7.6 UK 7.7 Italy 7.8 Russia 8 Middle East & Africa 8.1 Middle East & Africa Anti-tumor Drug by Region (2016-2021) 8.2 Middle East & Africa Anti-tumor Drug Market Size by Type (2016-2021) 8.3 Middle East & Africa Anti-tumor Drug Market Size by Application (2016-2021) 8.4 Egypt 8.5 South Africa 8.6 Israel 8.7 Turkey 8.8 GCC Countries 9 Market Drivers, Challenges and Trends 9.1 Market Drivers and Impact 9.1.1 Growing Demand from Key Regions 9.1.2 Growing Demand from Key Applications and Potential Industries 9.2 Market Challenges and Impact 9.3 Market Trends 10 Global Anti-tumor Drug Market Forecast 10.1 Global Anti-tumor Drug Forecast by Regions (2021-2026) 10.1.1 Global Anti-tumor Drug Forecast by Regions (2021-2026) 10.1.2 Americas Anti-tumor Drug Forecast 10.1.3 APAC Anti-tumor Drug Forecast 10.1.4 Europe Anti-tumor Drug Forecast 10.1.5 Middle East & Africa Anti-tumor Drug Forecast 10.2 Americas Anti-tumor Drug Forecast by Countries (2021-2026) 10.2.1 United States Anti-tumor Drug Market Forecast 10.2.2 Canada Anti-tumor Drug Market Forecast 10.2.3 Mexico Anti-tumor Drug Market Forecast 10.2.4 Brazil Anti-tumor Drug Market Forecast 10.3 APAC Anti-tumor Drug Forecast by Region (2021-2026) 10.3.1 China Anti-tumor Drug Market Forecast 10.3.2 Japan Anti-tumor Drug Market Forecast 10.3.3 Korea Anti-tumor Drug Market Forecast 10.3.4 Southeast Asia Anti-tumor Drug Market Forecast 10.3.5 India Anti-tumor Drug Market Forecast 10.3.6 Australia Anti-tumor Drug Market Forecast 10.4 Europe Anti-tumor Drug Forecast by Country (2021-2026) 10.4.1 Germany Anti-tumor Drug Market Forecast 10.4.2 France Anti-tumor Drug Market Forecast 10.4.3 UK Anti-tumor Drug Market Forecast 10.4.4 Italy Anti-tumor Drug Market Forecast 10.4.5 Russia Anti-tumor Drug Market Forecast 10.5 Middle East & Africa Anti-tumor Drug Forecast by Region (2021-2026) 10.5.1 Egypt Anti-tumor Drug Market Forecast 10.5.2 South Africa Anti-tumor Drug Market Forecast 10.5.3 Israel Anti-tumor Drug Market Forecast 10.5.4 Turkey Anti-tumor Drug Market Forecast 10.5.5 GCC Countries Anti-tumor Drug Market Forecast 10.6 Global Anti-tumor Drug Forecast by Type (2021-2026) 10.7 Global Anti-tumor Drug Forecast by Application (2021-2026) 11 Key Players Analysis 11.1 Roche 11.1.1 Roche Company Information 11.1.2 Roche Anti-tumor Drug Product Offered 11.1.3 Roche Anti-tumor Drug Revenue, Gross Margin and Market Share (2019-2021) 11.1.4 Roche Main Business Overview 11.1.5 Roche Latest Developments 11.2 Novartis 11.2.1 Novartis Company Information 11.2.2 Novartis Anti-tumor Drug Product Offered 11.2.3 Novartis Anti-tumor Drug Revenue, Gross Margin and Market Share (2019-2021) 11.2.4 Novartis Main Business Overview 11.2.5 Novartis Latest Developments 11.3 Celgene 11.3.1 Celgene Company Information 11.3.2 Celgene Anti-tumor Drug Product Offered 11.3.3 Celgene Anti-tumor Drug Revenue, Gross Margin and Market Share (2019-2021) 11.3.4 Celgene Main Business Overview 11.3.5 Celgene Latest Developments 11.4 Bristol-Myers Squibb 11.4.1 Bristol-Myers Squibb Company Information 11.4.2 Bristol-Myers Squibb Anti-tumor Drug Product Offered 11.4.3 Bristol-Myers Squibb Anti-tumor Drug Revenue, Gross Margin and Market Share (2019-2021) 11.4.4 Bristol-Myers Squibb Main Business Overview 11.4.5 Bristol-Myers Squibb Latest Developments 11.5 Amgen 11.5.1 Amgen Company Information 11.5.2 Amgen Anti-tumor Drug Product Offered 11.5.3 Amgen Anti-tumor Drug Revenue, Gross Margin and Market Share (2019-2021) 11.5.4 Amgen Main Business Overview 11.5.5 Amgen Latest Developments 11.6 Johnson & Johnson 11.6.1 Johnson & Johnson Company Information 11.6.2 Johnson & Johnson Anti-tumor Drug Product Offered 11.6.3 Johnson & Johnson Anti-tumor Drug Revenue, Gross Margin and Market Share (2019-2021) 11.6.4 Johnson & Johnson Main Business Overview 11.6.5 Johnson & Johnson Latest Developments 11.7 Pfizer 11.7.1 Pfizer Company Information 11.7.2 Pfizer Anti-tumor Drug Product Offered 11.7.3 Pfizer Anti-tumor Drug Revenue, Gross Margin and Market Share (2019-2021) 11.7.4 Pfizer Main Business Overview 11.7.5 Pfizer Latest Developments 11.8 Takeda 11.8.1 Takeda Company Information 11.8.2 Takeda Anti-tumor Drug Product Offered 11.8.3 Takeda Anti-tumor Drug Revenue, Gross Margin and Market Share (2019-2021) 11.8.4 Takeda Main Business Overview 11.8.5 Takeda Latest Developments 11.9 Eli Lilly 11.9.1 Eli Lilly Company Information 11.9.2 Eli Lilly Anti-tumor Drug Product Offered 11.9.3 Eli Lilly Anti-tumor Drug Revenue, Gross Margin and Market Share (2019-2021) 11.9.4 Eli Lilly Main Business Overview 11.9.5 Eli Lilly Latest Developments 11.10 AstraZeneca 11.10.1 AstraZeneca Company Information 11.10.2 AstraZeneca Anti-tumor Drug Product Offered 11.10.3 AstraZeneca Anti-tumor Drug Revenue, Gross Margin and Market Share (2019-2021) 11.10.4 AstraZeneca Main Business Overview 11.10.5 AstraZeneca Latest Developments 11. Astellas 11.11.1 Astellas Company Information 11.11.2 Astellas Anti-tumor Drug Product Offered 11.11.3 Astellas Anti-tumor Drug Revenue, Gross Margin and Market Share (2019-2021) 11.11.4 Astellas Main Business Overview 11.11.5 Astellas Latest Developments 11.12 Merck & Co 11.12.1 Merck & Co Company Information 11.12.2 Merck & Co Anti-tumor Drug Product Offered 11.12.3 Merck & Co Anti-tumor Drug Revenue, Gross Margin and Market Share (2019-2021) 11.12.4 Merck & Co Main Business Overview 11.12.5 Merck & Co Latest Developments 11.13 Sanofi 11.13.1 Sanofi Company Information 11.13.2 Sanofi Anti-tumor Drug Product Offered 11.13.3 Sanofi Anti-tumor Drug Revenue, Gross Margin and Market Share (2019-2021) 11.13.4 Sanofi Main Business Overview 11.13.5 Sanofi Latest Developments 11.14 Bayer 11.14.1 Bayer Company Information 11.14.2 Bayer Anti-tumor Drug Product Offered 11.14.3 Bayer Anti-tumor Drug Revenue, Gross Margin and Market Share (2019-2021) 11.14.4 Bayer Main Business Overview 11.14.5 Bayer Latest Developments 11.15 Biogen Idec 11.15.1 Biogen Idec Company Information 11.15.2 Biogen Idec Anti-tumor Drug Product Offered 11.15.3 Biogen Idec Anti-tumor Drug Revenue, Gross Margin and Market Share (2019-2021) 11.15.4 Biogen Idec Main Business Overview 11.15.5 Biogen Idec Latest Developments 11.16 Eisai 11.16.1 Eisai Company Information 11.16.2 Eisai Anti-tumor Drug Product Offered 11.16.3 Eisai Anti-tumor Drug Revenue, Gross Margin and Market Share (2019-2021) 11.16.4 Eisai Main Business Overview 11.16.5 Eisai Latest Developments 11.17 Teva 11.17.1 Teva Company Information 11.17.2 Teva Anti-tumor Drug Product Offered 11.17.3 Teva Anti-tumor Drug Revenue, Gross Margin and Market Share (2019-2021) 11.17.4 Teva Main Business Overview 11.17.5 Teva Latest Developments 11.18 Otsuka 11.18.1 Otsuka Company Information 11.18.2 Otsuka Anti-tumor Drug Product Offered 11.18.3 Otsuka Anti-tumor Drug Revenue, Gross Margin and Market Share (2019-2021) 11.18.4 Otsuka Main Business Overview 11.18.5 Otsuka Latest Developments 12 Research Findings and Conclusion

List of Tables Table 1. Anti-tumor Drug Market Size CAGR by Region (2020-2026) & ($ Millions) Table 2. Major Players of Cytotoxic Drugs Table 3. Major Players of Non-cytotoxic Drugs Table 4. Anti-tumor Drug Market Size CAGR by Type (2020-2026) & ($ Millions) Table 5. Global Anti-tumor Drug Market Size by Type (2016-2021) & ($ Millions) Table 6. Global Anti-tumor Drug Market Size Market Share by Type (2016-2021) Table 7. Anti-tumor Drug Market Size CAGR by Application (2016-2021) & ($ Millions) Table 8. Global Anti-tumor Drug Market Size by Application (2016-2021) & ($ Millions) Table 9. Global Anti-tumor Drug Market Size Market Share by Application (2016-2021) Table 10. Global Anti-tumor Drug Revenue by Players (2019-2021E) & ($ Millions) Table 11. Global Anti-tumor Drug Revenue Market Share by Players (2019-2021E) Table 12. Anti-tumor Drug Key Players Head office and Products Offered Table 13. Anti-tumor Drug Concentration Ratio (CR3, CR5 and CR10) & (2019-2021E) Table 14. New Products and Potential Entrants Table 15. Mergers & Acquisitions, Expansion Table 16. Global Anti-tumor Drug Market Size by Regions 2016-2021 & ($ Millions) Table 17. Global Anti-tumor Drug Market Size Market Share by Regions 2016-2021 Table 18. Americas Anti-tumor Drug Market Size by Country (2016-2021) & ($ Millions) Table 19. Americas Anti-tumor Drug Market Size Market Share by Country (2016-2021) Table 20. Americas Anti-tumor Drug Market Size by Type (2016-2021) & ($ Millions) Table 21. Americas Anti-tumor Drug Market Size Market Share by Type (2016-2021) Table 22. Americas Anti-tumor Drug Market Size by Application (2016-2021) & ($ Millions) Table 23. Americas Anti-tumor Drug Market Size Market Share by Application (2016-2021) Table 24. APAC Anti-tumor Drug Market Size by Region (2016-2021) & ($ Millions) Table 25. APAC Anti-tumor Drug Market Size Market Share by Region (2016-2021) Table 26. APAC Anti-tumor Drug Market Size by Type (2016-2021) & ($ Millions) Table 27. APAC Anti-tumor Drug Market Size Market Share by Type (2016-2021) Table 28. APAC Anti-tumor Drug Market Size by Application (2016-2021) & ($ Millions) Table 29. APAC Anti-tumor Drug Market Size Market Share by Application (2016-2021) Table 30. Europe Anti-tumor Drug Market Size by Country (2016-2021) & ($ Millions) Table 31. Europe Anti-tumor Drug Market Size Market Share by Country (2016-2021) Table 32. Europe Anti-tumor Drug Market Size by Type (2016-2021) & ($ Millions) Table 33. Europe Anti-tumor Drug Market Size Market Share by Type (2016-2021) Table 34. Europe Anti-tumor Drug Market Size by Application (2016-2021) & ($ Millions) Table 35. Europe Anti-tumor Drug Market Size Market Share by Application (2016-2021) Table 36. Middle East & Africa Anti-tumor Drug Market Size by Region (2016-2021) & ($ Millions) Table 37. Middle East & Africa Anti-tumor Drug Market Size Market Share by Region (2016-2021) Table 38. Middle East & Africa Anti-tumor Drug Market Size by Type (2016-2021) & ($ Millions) Table 39. Middle East & Africa Anti-tumor Drug Market Size Market Share by Type (2016-2021) Table 40. Middle East & Africa Anti-tumor Drug Market Size by Application (2016-2021) & ($ Millions) Table 41. Middle East & Africa Anti-tumor Drug Market Size Market Share by Application (2016-2021) Table 42. Key and Potential Regions of Anti-tumor Drug Table 43. Key Application and Potential Industries of Anti-tumor Drug Table 44. Key Challenges of Anti-tumor Drug Table 45. Key Trends of Anti-tumor Drug Table 46. Global Anti-tumor Drug Market Size Forecast by Regions (2021-2026) & ($ Millions) Table 47. Global Anti-tumor Drug Market Size Market Share Forecast by Regions (2021-2026) Table 48. Global Anti-tumor Drug Market Size Forecast by Type (2021-2026) & ($ Millions) Table 49. Global Anti-tumor Drug Market Size Market Share Forecast by Type (2021-2026) Table 50. Global Anti-tumor Drug Market Size Forecast by Application (2021-2026) & ($ Millions) Table 51. Global Anti-tumor Drug Market Size Market Share Forecast by Application (2021-2026) Table 52. Roche Details, Company Type, Anti-tumor Drug Area Served and Its Competitors Table 53. Roche Anti-tumor Drug Product Offered Table 54. Roche Anti-tumor Drug Revenue ($ million), Gross Margin and Market Share (2019-2021E) Table 55. Roche Main Business Table 56. Roche Latest Developments Table 57. Novartis Details, Company Type, Anti-tumor Drug Area Served and Its Competitors Table 58. Novartis Anti-tumor Drug Product Offered Table 59. Novartis Main Business Table 60. Novartis Anti-tumor Drug Revenue ($ million), Gross Margin and Market Share (2019-2021E) Table 61. Novartis Latest Developments Table 62. Celgene Details, Company Type, Anti-tumor Drug Area Served and Its Competitors Table 63. Celgene Anti-tumor Drug Product Offered Table 64. Celgene Main Business Table 65. Celgene Anti-tumor Drug Revenue ($ million), Gross Margin and Market Share (2019-2021E) Table 66. Celgene Latest Developments Table 67. Bristol-Myers Squibb Details, Company Type, Anti-tumor Drug Area Served and Its Competitors Table 68. Bristol-Myers Squibb Anti-tumor Drug Product Offered Table 69. Bristol-Myers Squibb Main Business Table 70. Bristol-Myers Squibb Anti-tumor Drug Revenue ($ million), Gross Margin and Market Share (2019-2021E) Table 71. Bristol-Myers Squibb Latest Developments Table 72. Amgen Details, Company Type, Anti-tumor Drug Area Served and Its Competitors Table 73. Amgen Anti-tumor Drug Product Offered Table 74. Amgen Main Business Table 75. Amgen Anti-tumor Drug Revenue ($ million), Gross Margin and Market Share (2019-2021E) Table 76. Amgen Latest Developments Table 77. Johnson & Johnson Details, Company Type, Anti-tumor Drug Area Served and Its Competitors Table 78. Johnson & Johnson Anti-tumor Drug Product Offered Table 79. Johnson & Johnson Main Business Table 80. Johnson & Johnson Anti-tumor Drug Revenue ($ million), Gross Margin and Market Share (2019-2021E) Table 81. Johnson & Johnson Latest Developments Table 82. Pfizer Details, Company Type, Anti-tumor Drug Area Served and Its Competitors Table 83. Pfizer Anti-tumor Drug Product Offered Table 84. Pfizer Main Business Table 85. Pfizer Anti-tumor Drug Revenue ($ million), Gross Margin and Market Share (2019-2021E) Table 86. Pfizer Latest Developments Table 87. Takeda Details, Company Type, Anti-tumor Drug Area Served and Its Competitors Table 88. Takeda Anti-tumor Drug Product Offered Table 89. Takeda Main Business Table 90. Takeda Anti-tumor Drug Revenue ($ million), Gross Margin and Market Share (2019-2021E) Table 91. Takeda Latest Developments Table 92. Eli Lilly Details, Company Type, Anti-tumor Drug Area Served and Its Competitors Table 93. Eli Lilly Anti-tumor Drug Product Offered Table 94. Eli Lilly Main Business Table 95. Eli Lilly Anti-tumor Drug Revenue ($ million), Gross Margin and Market Share (2019-2021E) Table 96. Eli Lilly Latest Developments Table 97. AstraZeneca Details, Company Type, Anti-tumor Drug Area Served and Its Competitors Table 98. AstraZeneca Anti-tumor Drug Product Offered Table 99. AstraZeneca Main Business Table 100. AstraZeneca Anti-tumor Drug Revenue ($ million), Gross Margin and Market Share (2019-2021E) Table 101. AstraZeneca Latest Developments Table 102. Astellas Details, Company Type, Anti-tumor Drug Area Served and Its Competitors Table 103. Astellas Anti-tumor Drug Product Offered Table 104. Astellas Anti-tumor Drug Revenue ($ million), Gross Margin and Market Share (2019-2021E) Table 105. Astellas Main Business Table 106. Astellas Latest Developments Table 107. Merck & Co Details, Company Type, Anti-tumor Drug Area Served and Its Competitors Table 108. Merck & Co Anti-tumor Drug Product Offered Table 109. Merck & Co Main Business Table 110. Merck & Co Anti-tumor Drug Revenue ($ million), Gross Margin and Market Share (2019-2021E) Table 111. Merck & Co Latest Developments Table 112. Sanofi Details, Company Type, Anti-tumor Drug Area Served and Its Competitors Table 113. Sanofi Anti-tumor Drug Product Offered Table 114. Sanofi Main Business Table 115. Sanofi Anti-tumor Drug Revenue ($ million), Gross Margin and Market Share (2019-2021E) Table 116. Sanofi Latest Developments Table 117. Bayer Details, Company Type, Anti-tumor Drug Area Served and Its Competitors Table 118. Bayer Anti-tumor Drug Product Offered Table 119. Bayer Main Business Table 120. Bayer Anti-tumor Drug Revenue ($ million), Gross Margin and Market Share (2019-2021E) Table 121. Bayer Latest Developments Table 122. Biogen Idec Details, Company Type, Anti-tumor Drug Area Served and Its Competitors Table 123. Biogen Idec Anti-tumor Drug Product Offered Table 124. Biogen Idec Main Business Table 125. Biogen Idec Anti-tumor Drug Revenue ($ million), Gross Margin and Market Share (2019-2021E) Table 126. Biogen Idec Latest Developments Table 127. Eisai Details, Company Type, Anti-tumor Drug Area Served and Its Competitors Table 128. Eisai Anti-tumor Drug Product Offered Table 129. Eisai Main Business Table 130. Eisai Anti-tumor Drug Revenue ($ million), Gross Margin and Market Share (2019-2021E) Table 131. Eisai Latest Developments Table 132. Teva Details, Company Type, Anti-tumor Drug Area Served and Its Competitors Table 133. Teva Anti-tumor Drug Product Offered Table 134. Teva Main Business Table 135. Teva Anti-tumor Drug Revenue ($ million), Gross Margin and Market Share (2019-2021E) Table 136. Teva Latest Developments Table 137. Otsuka Details, Company Type, Anti-tumor Drug Area Served and Its Competitors Table 138. Otsuka Anti-tumor Drug Product Offered Table 139. Otsuka Main Business Table 140. Otsuka Anti-tumor Drug Revenue ($ million), Gross Margin and Market Share (2019-2021E) Table 141. Otsuka Latest Developments List of Figures Figure 1. Anti-tumor Drug Report Years Considered Figure 2. Research Objectives Figure 3. Research Methodology Figure 4. Research Process and Data Source Figure 5. Global Anti-tumor Drug Market Size Growth Rate 2016-2026 ($ Millions) Figure 6. Global Anti-tumor Drug Market Size Market Share by Type in 2020 Figure 7. Anti-tumor Drug in Alkylating Agents Figure 8. Global Anti-tumor Drug Market: Alkylating Agents (2016-2021) & ($ Millions) Figure 9. Anti-tumor Drug in Anti-Metabolism Drugs Figure 10. Global Anti-tumor Drug Market: Anti-Metabolism Drugs (2016-2021) & ($ Millions) Figure 11. Anti-tumor Drug in Platinum Antineoplastic Agents Figure 12. Global Anti-tumor Drug Market: Platinum Antineoplastic Agents (2016-2021) & ($ Millions) Figure 13. Anti-tumor Drug in Anthracycline Antitumor Drugs Figure 14. Global Anti-tumor Drug Market: Anthracycline Antitumor Drugs (2016-2021) & ($ Millions) Figure 15. Anti-tumor Drug in Microtubule Stabilizer Figure 16. Global Anti-tumor Drug Market: Microtubule Stabilizer (2016-2021) & ($ Millions) Figure 17. Anti-tumor Drug in Endocrine Therapy Drugs Figure 18. Global Anti-tumor Drug Market: Endocrine Therapy Drugs (2016-2021) & ($ Millions) Figure 19. Anti-tumor Drug in Immunotherapy Drugs Figure 20. Global Anti-tumor Drug Market: Immunotherapy Drugs (2016-2021) & ($ Millions) Figure 21. Anti-tumor Drug in Gene Therapy Drugs Figure 22. Global Anti-tumor Drug Market: Gene Therapy Drugs (2016-2021) & ($ Millions) Figure 23. Anti-tumor Drug in Targeted Antineoplastic Drugs Figure 24. Global Anti-tumor Drug Market: Targeted Antineoplastic Drugs (2016-2021) & ($ Millions) Figure 25. Global Anti-tumor Drug Market Size Market Share by Application in 2020 Figure 26. Global Anti-tumor Drug Revenue Market Share by Player in 2020 Figure 27. Global Anti-tumor Drug Market Size Market Share by Regions (2016-2021) Figure 28. Americas Anti-tumor Drug Market Size 2016-2021 ($ Millions) Figure 29. APAC Anti-tumor Drug Market Size 2016-2021 ($ Millions) Figure 30. Europe Anti-tumor Drug Market Size 2016-2021 ($ Millions) Figure 31. Middle East & Africa Anti-tumor Drug Market Size 2016-2021 ($ Millions) Figure 32. Americas Anti-tumor Drug Market Size Market Share by Country in 2020 Figure 33. Americas Anti-tumor Drug Market Size Market Share by Type in 2020 Figure 34. Americas Anti-tumor Drug Market Size Market Share by Application in 2020 Figure 35. United States Anti-tumor Drug Market Size Growth 2016-2021 ($ Millions) Figure 36. Canada Anti-tumor Drug Market Size Growth 2016-2021 ($ Millions) Figure 37. Mexico Anti-tumor Drug Market Size Growth 2016-2021 ($ Millions) Figure 38. APAC Anti-tumor Drug Market Size Market Share by Regions in 2020 Figure 39. APAC Anti-tumor Drug Market Size Market Share by Type in 2020 Figure 40. APAC Anti-tumor Drug Market Size Market Share by Application in 2020 Figure 41. China Anti-tumor Drug Market Size Growth 2016-2021 ($ Millions) Figure 42. Japan Anti-tumor Drug Market Size Growth 2016-2021 ($ Millions) Figure 43. Korea Anti-tumor Drug Market Size Growth 2016-2021 ($ Millions) Figure 44. Southeast Asia Anti-tumor Drug Market Size Growth 2016-2021 ($ Millions) Figure 45. India Anti-tumor Drug Market Size Growth 2016-2021 ($ Millions) Figure 46. Australia Anti-tumor Drug Market Size Growth 2016-2021 ($ Millions) Figure 47. Europe Anti-tumor Drug Market Size Market Share by Country in 2020 Figure 48. Europe Anti-tumor Drug Market Size Market Share by Type in 2020 Figure 49. Europe Anti-tumor Drug Market Size Market Share by Application in 2020 Figure 50. Germany Anti-tumor Drug Market Size Growth 2016-2021 ($ Millions) Figure 51. France Anti-tumor Drug Market Size Growth 2016-2021 ($ Millions) Figure 52. UK Anti-tumor Drug Market Size Growth 2016-2021 ($ Millions) Figure 53. Italy Anti-tumor Drug Market Size Growth 2016-2021 ($ Millions) Figure 54. Russia Anti-tumor Drug Market Size Growth 2016-2021 ($ Millions) Figure 55. Middle East & Africa Anti-tumor Drug Market Size Market Share by Region in 2020 Figure 56. Middle East & Africa Anti-tumor Drug Market Size Market Share by Type in 2020 Figure 57. Middle East & Africa Anti-tumor Drug Market Size Market Share by Application in 2020 Figure 58. Egypt Anti-tumor Drug Market Size Growth 2016-2021 ($ Millions) Figure 59. South Africa Anti-tumor Drug Market Size Growth 2016-2021 ($ Millions) Figure 60. Israel Anti-tumor Drug Market Size Growth 2016-2021 ($ Millions) Figure 61. Turkey Anti-tumor Drug Market Size Growth 2016-2021 ($ Millions) Figure 62. GCC Country Anti-tumor Drug Market Size Growth 2016-2021 ($ Millions) Figure 63. Americas Anti-tumor Drug Market Size 2021-2026 ($ Millions) Figure 64. APAC Anti-tumor Drug Market Size 2021-2026 ($ Millions) Figure 65. Europe Anti-tumor Drug Market Size 2021-2026 ($ Millions) Figure 66. Middle East & Africa Anti-tumor Drug Market Size 2021-2026 ($ Millions) Figure 67. United States Anti-tumor Drug Market Size 2021-2026 ($ Millions) Figure 68. Canada Anti-tumor Drug Market Size 2021-2026 ($ Millions) Figure 69. Mexico Anti-tumor Drug Market Size 2021-2026 ($ Millions) Figure 70. Brazil Anti-tumor Drug Market Size 2021-2026 ($ Millions) Figure 71. China Anti-tumor Drug Market Size 2021-2026 ($ Millions) Figure 72. Japan Anti-tumor Drug Market Size 2021-2026 ($ Millions) Figure 73. Korea Anti-tumor Drug Market Size 2021-2026 ($ Millions) Figure 74. Southeast Asia Anti-tumor Drug Market Size 2021-2026 ($ Millions) Figure 75. India Anti-tumor Drug Market Size 2021-2026 ($ Millions) Figure 76. Australia Anti-tumor Drug Market Size 2021-2026 ($ Millions) Figure 77. Germany Anti-tumor Drug Market Size 2021-2026 ($ Millions) Figure 78. France Anti-tumor Drug Market Size 2021-2026 ($ Millions) Figure 79. UK Anti-tumor Drug Market Size 2021-2026 ($ Millions) Figure 80. Italy Anti-tumor Drug Market Size 2021-2026 ($ Millions) Figure 81. Russia Anti-tumor Drug Market Size 2021-2026 ($ Millions) Figure 82. Spain Anti-tumor Drug Market Size 2021-2026 ($ Millions) Figure 83. Egypt Anti-tumor Drug Market Size 2021-2026 ($ Millions) Figure 84. South Africa Anti-tumor Drug Market Size 2021-2026 ($ Millions) Figure 85. Israel Anti-tumor Drug Market Size 2021-2026 ($ Millions) Figure 86. Turkey Anti-tumor Drug Market Size 2021-2026 ($ Millions) Figure 87. GCC Country Anti-tumor Drug Market Size 2021-2026 ($ Millions)